At a glance
ClinicalIndex Comparison RecordN/ACompleted· 285 enrolled
Drug / intervention
Juvéderm® Volbella with Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement
In Brief
A clinical study evaluating Juvéderm® Volbella with Lidocaine and Restylane-L® for Lip Volume Enhancement. Completed, enrolled 285 participants across 2 sites in 2 countries.
Detailed Summary
The purpose of this study is evaluate lip fullness 3 months following treatment with Juvéderm® Volbella with Lidocaine or Restylane-L®
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLip Volume Enhancement
CountriesFrance, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2012
First PostedApr 2012
Primary CompletionJun 2013
Study CompletionJan 2014
TodayJul 2026
First PostedApr 17, 2012
Enrollment StartApr 1, 2012
Primary CompletionJun 1, 2013
Study CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 14.2 years ago
Interventions
Juvéderm® Volbella with Lidocainedevice
Up to 4.0 mL at the discretion of the Investigator to achieve optimal results
Restylane-L®device
Up to 4.0 mL at the discretion of the Investigator to achieve optimal results